<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05616234</url>
  </required_header>
  <id_info>
    <org_study_id>1956959</org_study_id>
    <nct_id>NCT05616234</nct_id>
  </id_info>
  <brief_title>Exercise-induced Changes in Exosomes</brief_title>
  <official_title>Exercise-induced Changes in Exosomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed study aims to shed light on the function/importance/relevance of&#xD;
      exercise-induced changes in exosomes to connective tissues. Exosomes are known to increase&#xD;
      robustly in response to exercise. We have previously shown that serum isolated from subjects&#xD;
      after they lift heavy weights increases human engineered ligament collagen content and&#xD;
      mechanics more than serum from before they lift weight. Further, we showed that&#xD;
      exercise-induced changes in hormones could not explain the change in ligament structure or&#xD;
      function. These data indicate that there is a significant gap in our understanding of&#xD;
      muscle-connective tissue crosstalk. To address this gap, the current proposal seeks to: i)&#xD;
      isolate and sequence exosomal RNA (long non-coding, miR, and mRNA) and ii) determine whether&#xD;
      exosomes isolated from serum after exercise increase engineered ligament mechanics and&#xD;
      collagen content.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 7, 2022</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Collagen content of ligament constructs</measure>
    <time_frame>15 min post-exercise</time_frame>
    <description>Ligament constructs will be treated for 7 days with experimental feed medium containing serum, or exosomes isolated from serum, obtained at baseline or post-exercise for determination of collagen content using a hydroxyproline assay.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ultimate tensile stress and modulus of ligament constructs</measure>
    <time_frame>15 min post-exercise</time_frame>
    <description>ligament constructs will be treated for 7 days with experimental feed medium containing serum, or exosomes isolated from serum, obtained at baseline or post-exercise for determination of ultimate tensile stress and modulus.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exosomal RNA</measure>
    <time_frame>15 min post-exercise</time_frame>
    <description>Isolation and sequencing of exosomal RNA from serum obtained at baseline or post-exercise.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Exosomes</condition>
  <condition>Connective Tissue</condition>
  <condition>Exercise</condition>
  <arm_group>
    <arm_group_label>Exercise trial</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will perform a bout of exercise. In addition, a baseline and post-exercise blood sample will be drawn.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Resistance Exercise</intervention_name>
    <description>Participants will perform a bout of lower body resistance exercise consisting of leg press, leg extension and leg curls.</description>
    <arm_group_label>Exercise trial</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Young healthy adults (18-35 y)&#xD;
&#xD;
          -  Experience with exercise (&gt;1y)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Smoking&#xD;
&#xD;
          -  Receiving any medication that may interfere with the study outcomes&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Keith Baar, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Davis</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kevin Paulussen, PhD</last_name>
    <phone>2177214479</phone>
    <email>kpaulussen@ucdavis.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Keith Baar, PhD</last_name>
    <email>kbaar@ucdavis.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hickey Laboratory</name>
      <address>
        <city>Davis</city>
        <state>California</state>
        <zip>95616</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin Paulussen, PhD</last_name>
      <email>kpaulussen@ucdavis.edu</email>
    </contact>
    <contact_backup>
      <last_name>Keith Baar, PhD</last_name>
      <email>kbaar@ucdavis.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 7, 2022</study_first_submitted>
  <study_first_submitted_qc>November 7, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 15, 2022</study_first_posted>
  <last_update_submitted>November 7, 2022</last_update_submitted>
  <last_update_submitted_qc>November 7, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

